Announcements
- IBA déclaration intermédiaire - Premier trimestre 2024
- IBA Business Update – First Quarter 2024
- IBA : 2024 AGM - Convening Notice
- IBA signe un contrat avec Yale New Haven Health et Hartford HealthCare pour l’installation d’une solution de protonthérapie Proteus®ONE dans le Connecticut, aux États-Unis
- IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
- IBA SA – NOTIFICATION TRANSPARENCE
- Iba – Transparency Notification
- IBA Reports Full Year 2023 Results
- IBA publie ses résultats annuels pour 2023
- IBA signs contract to install a Be-Efficient irradiation solution in Germany
More ▼
Key statistics
As of last trade Ion Beam Applications SA (IOB:FRA) traded at 14.08, -16.78% below its 52-week high of 16.92, set on Jun 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.08 |
---|---|
High | 14.08 |
Low | 14.08 |
Bid | 14.42 |
Offer | 14.50 |
Previous close | 13.86 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.28m |
Free float | 21.07m |
P/E (TTM) | -- |
Market cap | 431.82m EUR |
EPS (TTM) | -0.3139 EUR |
Annual div (ADY) | 0.21 EUR |
---|---|
Annual div yield (ADY) | 1.56% |
Div ex-date | Jun 29 2023 |
Div pay-date | Jul 03 2023 |
Data delayed at least 15 minutes, as of May 29 2024 07:09 BST.
More ▼